Recently, aggravation of systemic inflammation and increased mortality rate and organ injuries in patients infected with SARS-CoV2 also receiving insulin treatment for type 2 diabetes mellitus has been reported in a study by Yu et al. [17]. The gene discussed is INS; the disease is type 2 diabetes mellitus.